Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin

Endocrinology

Volumn 147, Issue 5, 2006, Pages 2432-2441

  Andreelli, Fabrizio ^a   Foretz, Marc ^a   Knauf, Claude ^b   Cani, Patrice D ^b   Perrin, Christophe ^b   Iglesias, Miguel A ^b   Pillot, Bruno ^a   Bado, André ^a   Tronche, François ^c   Mithieux, Gilles ^a   Vaulont, Sophie ^a   Burcelin, Rémy ^b,c   Viollet, Benoit ^a  

^a INSERM   (France)

^b CHU RANGUEIL   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE 6 PHOSPHATASE; INSULIN; LEPTIN; LIVER ENZYME; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; PROTEIN SUBUNIT; PYRUVATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME REGULATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CATALYSIS; DISEASE MODELS, ANIMAL; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE-6-PHOSPHATASE; HYPERGLYCEMIA; INSECT HORMONES; INSULIN; LEPTIN; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; MODELS, STATISTICAL; MULTIENZYME COMPLEXES; OLIGOPEPTIDES; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PYRROLIDONECARBOXYLIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33645884425     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0898     Document Type: Article

References (41)

1. Nordlie RC, Foster JD, Lange AJ 1999 Regulation of glucose production by the liver. Annu Rev Nutr 19:379-406
2. Cherrington AD 1999 Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-1214
3. Roden M, Petersen KF, Shulman GI 2001 Nuclear magnetic resonance studies of hepatic glucose metabolism in humans. Recent Prog Horm Res 56:219-237
4. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI 1992 Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327
5. Consoli A, Nurjhan N, Capani F, Gerich J 1989 Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550-557
6. Hardie DG 2004 The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 117:5479-5487
7. Bergeron R, Previs SF, Cline GW, Perret P, Russell RR, Young LH, Shulman GI 2001 Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50:1076-1082
8. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174
9. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE 2001 The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
10. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
11. Kim MS, Park JY, Namkoong C, Jang P-G, Ryu J-W, Song H-S, Yun J-Y, Namgoong I-S, Ha J, Park I-S, Lee I-K, Viollet B, Youn JH, Lee H-K, Lee K-U 2004 Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10:727-733
12. Minokoshi Y, Alquier T, Furukawa N, Kim Y-B, Lee A, Xue B, Mu J, Foufelle F, Ferré P, Birnbaum MJ, Stuck BJ, Kahn BB 2004 AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428:569-574
13. Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, Kiens B 2000 Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 528(Pt 1):221-226
14. Jorgensen SB, Viollet B, Andreelli F, Frøsig C, Birk JP, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JFP 2004 Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279:1070-1079
15. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B 2005 Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54:1331-1339
16. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA 2004 Regulation of fasted blood glucose by resistin. Science 303:1195-1198
17. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JFP, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S 2003 The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111:91-98
18. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche F 2000 Hepatocyte-specific expression of Cre recombinase. Genesis 26:151-153
19. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B 2002 Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834-E842
20. Rajas F, Bruni N, Montano S, Zitoun C, Mithieux G 1999 The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. Gastroenterology 117:132-139
21. Jomain-Baum M, Schramm VL 1978 Kinetic mechanism of phosphoenolpyruvate carboxykinase (GTP) from rat liver cytosol. Product inhibition, isotope exchange at equilibrium, and partial reactions. J Biol Chem 253:3648-3659
22. Rajas F, Croset M, Zitoun C, Montano S, Mithieux G 2000 Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes 49:1165-1168
23. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ 1997 Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389:374-377
24. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D 2000 Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem J 346(Pt 3):659-669
25. Burcelin R, del Carmen Munoz M, Guillam MT, Thorens B 2000 Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway. J Biol Chem 275:10930-10936
26. Bergeron R, Russell 3rd RR, Young LH, Ren J-M, Marcucci M, Lee A, Shulman GI 1999 Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 276:E938-E944
27. Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C 2000 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49:896-903
28. Mithieux G, Guignot L, Bordet JC, Wiernsperger N 2002 Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51:139-143
29. Bady I, Zitoun C, Guignot L, Mithieux G 2002 Activation of liver G-6-Pase in response to insulin-induced hypoglycemia or epinephrine infusion in the rat. Am J Physiol Endocrinol Metab 282:E905-E910
30. Daniele N, Rajas F, Payrastre B, Mauco G, Zitoun C, Mithieux G 1999 Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6-phosphatase during refeeding. J Biol Chem 274:3597-3601
31. Rebrin K, Steil GM, Getty L, Bergman RN 1995 Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045
32. Shklyaev S, Aslanidi G, Tennant M, Prima V, Kohlbrenner E, Kroutov V, Campbell-Thompson M, Crawford J, Shek EW, Scarpace PJ, Zolotukhin S 2003 Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci USA 100:14217-14222
33. Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M 2004 Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432:1027-1032
34. Freedman BD, Lee EJ, Park Y, Jameson JL 2005 A dominant negative peroxisome proliferator-activated receptor-γ knock-in mouse exhibits features of the metabolic syndrome. J Biol Chem 280:17118-17125
35. Rossetti L, Massillon D, Barzilai N, Vuguin P, Chen W, Hawkins M, Wu J, Wang J 1997 Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 272:27758-27763
36. Burcelin R, Kamohara S, Li J, Tannenbaum GS, Charron MJ, Friedman JM 1999 Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 48:1264-1269
37. Chehab FF, Qiu J, Ogus S 2004 The use of animal models to dissect the biology of leptin. Recent Prog Horm Res 59:245-266
38. Hu E, Liang P, Spiegelman BM 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703
39. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
40. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J-i, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
41. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocr Rev 26:439-451